Trade Mark Journal No.2026/003 16 January 2026
WO0000001892884 (5,42)
Office of origin: United States of America
Date of International Registration:28 October 2025
Date of designation in the UK:
28 October 2025

International priority date claimed: 30 April 2025
(United States of America)
(99164847)
- Class 5
- Injectable dermal fillers; pharmaceutical preparations for use in dermatology; pharmaceutical preparation for skin care; pharmaceutical preparations for regenerative cell therapy; hyaluronic acid for pharmaceutical purposes; injectable dermal fillers for the treatment of facial lines, wrinkles and volume loss; pharmaceutical preparations for the treatment and prevention of facial lines, wrinkles and volume loss.
- Class 42
- Scientific research for medical purposes in the field of regenerative cell therapy; medical and scientific research information in the field of regenerative cell therapy; scientific investigations for medical purposes; scientific study and research in the field (s) of hyaluronic acid based fillers; pharmaceutical research and development; pharmaceutical products development.
LifeSprout, Inc.
Representative: Chang B. Hong MODALITY LAW PLLC, 265 Franklin Street, Ste 1702, Boston MA 02110, UNITED STATES OF AMERICA